Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations of FcRn inhibitors suitable for subcutaneous administration

Pharmaceutical formulations of FcRn inhibitors suitable for subcutaneous administration

US Patent 11591388 · Granted Feb 28, 2023

Estimated economic value: $45,461,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acids encoding GARP-TGF-beta 1 antibodies2020
GARP-TGF-β 1 IGG antibodies2020
GARP-TGF-beta 1 antibodies2019
Biologic compounds directed against death receptor 52015